Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis
Open Access
- 3 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 854991
Abstract
Endometriosis is a highly prevalent gynecological disease characterized by lesions in different sites. Regulation of specific estrogen pathways may favor the formation of distinct microenvironments and the progression of endometriosis. However, no study has simultaneously evaluated the gene and protein regulation of the main estrogen-synthesizing enzymes in endometriosis. Thus, our goals were to study the relationship between gene and protein expression of aromatase (CYP19A1 or ARO), steroid sulfatase (STS), and hydroxysteroid 17-beta dehydrogenase (HSD17B1) in superficial (SUP), ovarian (OMA), and deep infiltrating (DIE) endometriotic lesion sites as well as in the eutopic endometrium of patients with (EE) and without (control) endometriosis in the same and large cohort of patients. The site-specific expression of these enzymes within different cells (glandular and stromal components) was also explored. The study included 108 patients surgically diagnosed with endometriosis who provided biopsies of EE and endometriotic lesions and 16 disease-free patients who collected normal endometrium tissue. Our results showed that CYP19A1 was detected in all endometriosis tissues and was in higher levels than in control. Unique patterns of the STS and HSD17B1 levels showed that they were most closely regulated in all tissues, with manifestation at greater levels in DIE compared to the other endometriotic lesion sites, OMA and SUP. Gene and protein expression of ARO, STS, and HSD17B1 occurred at different rates in endometriotic sites or EE. The distinctive levels of these estrogen-synthesizing enzymes in each endometriotic site support the hypothesis of a tissue microenvironment that can both influence and be influenced by the expression of different estrogenic pathways, locally affecting the availability of estrogen needed for maintenance and progression of endometriotic lesions.Keywords
This publication has 64 references indexed in Scilit:
- Molecular features of sexual steroids on cartilage and boneRevista da Associação Médica Brasileira (English Edition), 2012
- miRNAs and estrogen actionTrends in Endocrinology & Metabolism, 2012
- Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumorsBMC Genomics, 2010
- Steroidogenic Enzyme and Key Decidualization Marker Dysregulation in Endometrial Stromal Cells from Women with Versus Without Endometriosis1Biology of Reproduction, 2009
- Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17β-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolismAmerican Journal of Obstetrics and Gynecology, 2007
- Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosisGynecological Endocrinology, 2007
- Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septumFertility and Sterility, 2006
- Pathogenesis of endometriosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Aromatase and EndometriosisSeminars in Reproductive Medicine, 2004
- The Analyses of 17 -Hydroxysteroid Dehydrogenase Isozymes in Human Endometrial Hyperplasia and CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2001